首页> 外文期刊>Journal of the American College of Surgeons >Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
【24h】

Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.

机译:胰腺腺鳞癌:比较切除和姑息治疗的单一机构经验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Adenosquamous carcinoma is a rare malignancy of the exocrine pancreas. Previous literature has reported dismal survival for these patients. We examined our single-institution experience with this tumor to compare survival for sugical resection and palliative therapy. STUDY DESIGN: Records were reviewed for patients with adenosquamous pancreatic cancer evaluated during the years 1985 to 2003. Pathology specimens were reviewed. Survival was calculated by Kaplan-Meier method and categorical variables were compared with Chi-square analysis. A p value < 0.05 was considered significant. RESULTS: Twenty-three patients were identified with adenosquamous carcinoma of the pancreas. Twelve patients underwent curative resection and 11 patients had either no surgery or a palliative bypass procedure. For the resection group the mean age was 69 years (7 men). In the nonoperative group the mean age was 65 years (6 men). Operative procedures included standard pancreaticoduodenectomy (PD), 4 patients; pyloruspreserving PD, 3 patients; and distal pancreatectomy, 5 patients. Median length of stay was 13.5 days (7-30 d). Morbidity included delayed gastric emptying (4 patients), leak (2 patients), superficial skin infection, abscess, and GI bleed (1 patient each). There was no operative or inhospital mortality in the resection group. For R0 resection median survival was 14.4 months compared to 8 months for R1 and 4.8 months for patients undergoing palliative therapies. CONCLUSIONS: The retrospective review of our single-institution experience with resection and palliative care for adenosquamous cancer of the pancreas has demonstrated a longer survival for patients that can undergo an R0 resection. Although this is a small series we continue to recommend resection for these patients.
机译:背景:腺鳞癌是一种罕见的外分泌胰腺恶性肿瘤。先前的文献报道了这些患者的不良生存。我们检查了我们对该肿瘤的单中心治疗经验,比较了手术切除和姑息治疗的生存率。研究设计:回顾性记录了1985年至2003年间评估的腺鳞状胰腺癌患者的病历。通过Kaplan-Meier方法计算生存率,并将分类变量与卡方分析进行比较。 p值<0.05被认为是显着的。结果:23例患者被确认患有胰腺腺鳞癌。 12例患者接受了根治性切除,11例患者未进行手术或姑息性旁路手术。切除组的平均年龄为69岁(7名男性)。非手术组的平均年龄为65岁(6名男性)。手术方法包括标准胰十二指肠切除术(PD),4例;保留幽门PD,3例;胰腺远端切除术5例。中位住院时间为13.5天(7-30天)。发病率包括胃排空延迟(4例),渗漏(2例),浅表皮肤感染,脓肿和胃肠道出血(每个1例)。切除组无手术或院内死亡。 R0切除术的中位生存期为14.4个月,而R1切除术的中位生存期为8个月,接受姑息治疗的患者为4.8个月。结论:我们对胰腺腺鳞癌的切除和姑息治疗的单机构经验的回顾性研究表明,可以接受R0切除的患者生存期更长。尽管这是一个小系列文章,我们仍继续建议对这些患者进行切除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号